Pregabalin 82619-0128-02
- Manufacturer
- Creekwood Pharmaceuticals Llc
- Dosage Form
- Capsule
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CV
- Marketing Start
- September 20, 2024
- Listing Expires
- December 31, 2026
- Application
- ANDA213423
Active Ingredients
| Ingredient | Strength |
|---|---|
| Pregabalin | 225 mg/1 |
Selected Package
82619-0128-02Selected500 CAPSULE in 1 BOTTLE (82619-128-02)
Other packages for this product(1)
90 CAPSULE in 1 BOTTLE (82619-128-01)